2,801
Views
16
CrossRef citations to date
0
Altmetric
Discussion Article

Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients

&
Pages S48-S53 | Received 06 Feb 2017, Accepted 05 Jul 2017, Published online: 20 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sibgha Batool, Saba Sohail, Fakhar ud Din, Ali H. Alamri, Ahmad S. Alqahtani, Mohammad A. Alshahrani, Mohammed A. Alshehri & Han Gon Choi. (2023) A detailed insight of the tumor targeting using nanocarrier drug delivery system. Drug Delivery 30:1.
Read now

Articles from other publishers (15)

Albert Y. Han, Marc‐Elie Nader, Keng Lam & Shirley Y. Su. (2023) Current status of sinonasal cancer survivorship care. Head & Neck 45:9, pages 2458-2468.
Crossref
Lori Zitelli, Catherine Palmer, Elizabeth Mamula, Jonas Johnson, Grant Rauterkus & Marci L. Nilsen. (2022) Hearing screening and amplifier uptake results in a multidisciplinary head and neck cancer survivorship clinic. Journal of Cancer Survivorship 17:3, pages 720-728.
Crossref
David S. Lee, Rajwant S. Mahal, Theresa Tharakan, Cathryn Collopy, Dorina Kallogjeri, Wade L. Thorstad, Douglas R. Adkins, Peter Oppelt, Jessica Ley, Cameron C. Wick & Jose Zevallos. (2023) Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV‐Related Oropharyngeal Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery 168:5, pages 1089-1096.
Crossref
Hideaki Okada & Koichi Kitagawa. (2022) Risk factors associated with cisplatin‐induced ototoxicity in Japanese patients with solid tumors. Cancer Medicine 12:7, pages 7904-7910.
Crossref
Sangwoo S. Kim, Hannah C. Liu & Loren K. Mell. (2023) Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin. Current Treatment Options in Oncology 24:3, pages 147-161.
Crossref
David S. Lee, Angela Schrader, Mark Warchol & Lavinia Sheets. (2022) Cisplatin exposure acutely disrupts mitochondrial bioenergetics in the zebrafish lateral-line organ. Hearing Research 426, pages 108513.
Crossref
Akira Ohkoshi, Ryoukichi Ikeda, Jun Suzuki, Takaya Yamamoto, Ryo Ishii, Kenjiro Higashi, Shun Wakamori, Yuki Nakayama, Ayako Nakanome, Takenori Ogawa & Yukio Katori. (2022) Eustachian Tube Functions in Concurrent Chemoradiotherapy for Head and Neck Cancer Patients. Indian Journal of Otolaryngology and Head & Neck Surgery 74:S3, pages 6307-6312.
Crossref
Fernanda Soares Aurélio Patatt, Laura Faustino Gonçalves, Karina Mary de Paiva & Patrícia Haas. (2022) Ototoxic effects of antineoplastic drugs: a systematic review. Brazilian Journal of Otorhinolaryngology 88:1, pages 130-140.
Crossref
Yuxin Qi, Wenping Yang, Shuang Liu, Fanjie Han, Haibin Wang, Yonghong Zhao, Yufa Zhou & Daijun Zhou. (2021) Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT. Cancer Cell International 21:1.
Crossref
Brian C. Deutsch, Cathryn Collopy, Dorina Kallogjeri & Jay F. Piccirillo. (2021) Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment. JAMA Otolaryngology–Head & Neck Surgery 147:2, pages 182.
Crossref
Ashley Kita, Johnny Saldate, Courtney Chang, Nitika Chellappa, Jeremy Jong, Riley Matsuda, Andrew Schmidt, Brandon Shih, Iram Shafqat, Kari Schoettler, Shiv Acharya, Stephanie Seidlits & Larry Hoffman. (2020) Implantable Drug Reservoir Devices for Inner Ear Delivery of Pharmacotherapeutics. Otolaryngology–Head and Neck Surgery 163:4, pages 791-798.
Crossref
Sarah M. Theodoroff & Dawn Konrad-Martin. (2020) Noise. Otolaryngologic Clinics of North America 53:4, pages 543-553.
Crossref
Katharine Fernandez, Katie K. Spielbauer, Aaron Rusheen, Lizhen Wang, Tiffany G. Baker, Stephen Eyles & Lisa L. Cunningham. (2020) Lovastatin protects against cisplatin-induced hearing loss in mice. Hearing Research 389, pages 107905.
Crossref
Dawn Konrad-Martin, Neela Swanson & Angela Garinis. (2019) A Guide to Coding and Billing for the Audiological Management of Patients Receiving Ototoxic Medical Treatments. Perspectives of the ASHA Special Interest Groups 4:5, pages 936-946.
Crossref
Christiane Matuschek, Jan Haussmann, Edwin Bölke, Stephan Gripp, Patrick J. Schuler, Bálint Tamaskovics, Peter Arne Gerber, Freddy-Joel Djiepmo-Njanang, Kai Kammers, Christian Plettenberg, Bahar Anooshahr, Klaus Orth & Wilfried Budach. (2018) Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis. Radiation Oncology 13:1.
Crossref